The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Identification and Verification of Immune-Related Gene Prognostic Signature Based on ssGSEA for Osteosarcoma
Open accessAbstract
Osteosarcoma is the most common malignant bone tumor in children and adolescence. Multiple immune-related genes have been reported in different cancers. The aim is to identify an immune-related gene signature for the prospective evaluation of prognosis for osteosarcoma patients. In this study, we evaluated the infiltration of immune cells in 101 osteosarcoma patients downloaded from TARGET using the ssGSEA to the RNA-sequencing of these patients, thus, high immune cell infiltration cluster, middle immune cell infiltration cluster and low immune cell infiltration cluster were generated. On the foundation of high immune cell infiltration cluster vs. low immune cell infiltration cluster and normal vs. osteosarcoma, we found 108 common differentially expressed genes which were sequentially submitted to univariate Cox and LASSO regression analysis. Furthermore, GSEA indicated some pathways with notable enrichment in the high- and low-immune cell infiltration cluster that may be helpful in understanding the potential mechanisms. Finally, we identified seven immune-related genes as prognostic signature for osteosarcoma. Kaplan-Meier analysis, ROC curve, univariate and multivariate Cox regression further confirmed that the seven immune-related genes signature was an innovative and significant prognostic factor independent of clinical features. These results of this study offer a means to predict the prognosis and survival of osteosarcoma patients with uncovered seven-gene signature as potential biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Min, J., Feng, Q., Liao, W., Liang, Y., Gong, C., Li, E., He, W., Yuan, R., & Wu, L. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12479 · Cited by 46
RetractedRobust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
Şenbabaoğlu, Y., Gejman, R. S., Winer, A. G., Liu, M., Van Allen, E. M., de Velasco, G., Miao, D., Ostrovnaya, I., Drill, E., Luna, A., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1092-z · Cited by 968
Osteosarcoma: a review of diagnosis, management, and treatment strategies.
Geller, D. S., & Gorlick, R. G. (2010) · PubMed · Cited by 475
Koirala, P., Roth, M. E., Gill, J., Piperdi, S., Chinai, J. M., Geller, D. S., Hoang, B. H., Park, A., Fremed, M. A., Zang, X., et al. (2016) · Scientific Reports · doi:10.1038/srep30093 · Cited by 267
Identification and validation of immune-related lncRNA prognostic signature for breast cancer
Shen, Y., Peng, X., & Shen, C. (2020) · Genomics · doi:10.1016/j.ygeno.2020.02.015 · Cited by 252
Heymann, M.-F., Lézot, F., & Heymann, D. (2019) · Cellular Immunology · doi:10.1016/j.cellimm.2017.10.011 · Cited by 233
Liu, Y., Qiao, L., Zhang, S., Wan, G., Chen, B., Zhou, P., Zhang, N., & Wang, Y. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.11.010 · Cited by 218
Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets
Yan, G.-N., Lv, Y.-F., & Guo, Q.-N. (2016) · Cancer Letters · doi:10.1016/j.canlet.2015.11.003 · Cited by 173
Chen, J., Liu, G., Wu, Y., Ma, J., Wu, H., Xie, Z., Chen, S., Yang, Y., Wang, S., Shen, P., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1076-1 · Cited by 163
Alpha-Smooth Muscle Actin (ACTA2) Is Required for Metastatic Potential of Human Lung Adenocarcinoma
Lee, H. W., Park, Y. M., Lee, S. J., Cho, H. J., Kim, D.-H., Lee, J.-I., Kang, M.-S., Seol, H. J., Shim, Y. M., Nam, D., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1181 · Cited by 141
Tumor Syndromes Predisposing to Osteosarcoma
Hameed, M., & Mandelker, D. (2018) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000190 · Cited by 109
Identification of key candidate genes and biological pathways in bladder cancer
Gao, X., Chen, Y., Chen, M., Wang, S., Wen, X., & Zhang, S. (2018) · PeerJ · doi:10.7717/peerj.6036 · Cited by 102
Guerra, A. D., Yeung, O. W. H., Qi, X., Kao, W. J., & Man, K. (2017) · Theranostics · doi:10.7150/thno.20251 · Cited by 92
Chen, J., Liu, G., Wu, Y., Ma, J., Wu, H.-F., Xie, Z., Chen, S., Yang, Y., Wang, S., Shen, P., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01193-7 · Cited by 92
Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
Hong, W., Yuan, H., Gu, Y., Liu, M., Ji, Y., Huang, Z., Yang, J., & Ma, L. (2020) · Cancer Cell International · doi:10.1186/s12935-020-1165-7 · Cited by 77
Cheng, L., Lu, W., Kulkarni, S. S., Pejovic, T. B., Yan, X. S., Chiang, J.-H., Hood, L., Odunsi, K. O., & Lin, B. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.01.041 · Cited by 75
The expression pattern of matrix-producing tumor stroma is of prognostic importance in breast cancer
Winslow, S., Lindquist, K. E., Edsjö, A., & Larsson, C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2864-2 · Cited by 73
VAMP8 facilitates cellular proliferation and temozolomide resistance in human glioma cells
Chen, Y., Meng, D., Wang, H., Sun, R., Wang, D., Wang, S., Fan, J., Zhao, Y., Wang, J., Yang, S. T., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou219 · Cited by 69
The Heterogeneity of Osteosarcoma: The Role Played by Cancer Stem Cells
Schiavone, K., Garnier, D., Heymann, M., & Heymann, D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-14366-4_11 · Cited by 68
Xie, L., Song, X., Yu, J., Guo, W., Wei, L., Liu, Y., & Wang, X.-W. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1050-9 · Cited by 50
Yuan, Y., Ji, C. F., Wang, J., Xu, M., Zhang, Y., Sun, P., & Liang, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00638 · Cited by 47
Ikeda, Y., Kiyotani, K., Yew, P. Y., Sato, S., Imai, Y., Yamaguchi, R., Miyano, S., Fujiwara, K., Hasegawa, K., & Nakamura, Y. (2017) · Oncology Reports · doi:10.3892/or.2017.5536 · Cited by 45
Identification of potential crucial genes and key pathways in osteosarcoma
Liu, J., Wu, S., Xie, X., Wang, Z., & Lei, Q. (2020) · Hereditas · doi:10.1186/s41065-020-00142-0 · Cited by 36
Pan, Y., Lu, L., Chen, J., Zhong, Y., & Dai, Z. (2018) · Hereditas · doi:10.1186/s41065-018-0061-9 · Cited by 35
Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma
Li, H., Yang, L., Wu, C., Xiao, Y., Mao, L., Chen, L., Zhang, W., & Sun, Z. (2019) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqz205 · Cited by 27
Self-citationHuang, M., Wang, H., Tok, T., Chang, H.-J., Chang, M., Cheng, T., Wang, J., & Lin, S. (2011) · DNA and Cell Biology · doi:10.1089/dna.2011.1365 · Cited by 26
Guan, X., Guan, Z., 季加孚, & Song, C. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01179-x · Cited by 24
An, H. J., Koh, H. M., & Song, D. H. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152607 · Cited by 17
Cited by
Jiang, C., Department of Cardiology, T. F. A. H. O. G. M. U., Jiang, W., & Department of Cardiology, N. T. C. M. H. (2022) · Mathematical Biosciences and Engineering · doi:10.3934/mbe.2022174 · Cited by 5
Metadata
- Authors
- Xiao, B., Liu, L., Li, A., Xiang, C., Wang, P., Li, H., & Xiao, T.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2020-12-15
- Volume
- 10
- Pages
- 607622-607622
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W3111627896
- Cited by
- 328
- References
- 31
- FWCI
- 15.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.